Literature DB >> 19367705

MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers.

Sören-Oliver Deininger1, Matthias P Ebert, Arne Fütterer, Marc Gerhard, Christoph Röcken.   

Abstract

Proteomics analyses have been exploited for the discovery of novel biomarkers for the early recognition and prognostic stratification of cancer patients. These analyses have now been extended to whole tissue sections by using a new tool, that is, MALDI imaging. This allows the spatial resolution of protein and peptides and their allocation to histoanatomical structures. Each MALDI imaging data set contains a large number of proteins and peptides, and their analysis can be quite tedious. We report here a new approach for the analysis of MALDI imaging results. Mass spectra are classified by hierarchical clustering by similarity and the resulting tissue classes are compared with the histology. The same approach is used to compare data sets of different patients. Tissue sections of gastric cancer and non-neoplastic mucosa obtained from 10 patients were forwarded to MALDI-Imaging. The in situ proteome expression was analyzed by hierarchical clustering and by principal component analysis (PCA). The reconstruction of images based on principal component scores allowed an unsupervised feature extraction of the data set. Generally, these images were in good agreement with the histology of the samples. The hierarchical clustering allowed a quick and intuitive access to the multidimensional information in the data set. It allowed a quick selection of spectra classes representative for different tissue features. The use of PCA for the comparison of MALDI spectra from different patients showed that the tumor and non-neoplastic mucosa are separated in the first three principal components. MALDI imaging in combination with hierarchical clustering allows the comprehensive analysis of the in situ cancer proteome in complex human cancers. On the basis of this cluster analysis, classification of complex human tissues is possible and opens the way for specific and cancer-related in situ biomarker analysis and identification.

Entities:  

Mesh:

Year:  2008        PMID: 19367705     DOI: 10.1021/pr8005777

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  68 in total

1.  S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging.

Authors:  Martin Nipp; Mareike Elsner; Benjamin Balluff; Stephan Meding; Hakan Sarioglu; Marius Ueffing; Sandra Rauser; Kristian Unger; Heinz Höfler; Axel Walch; Horst Zitzelsberger
Journal:  J Mol Med (Berl)       Date:  2011-09-22       Impact factor: 4.599

2.  High speed data processing for imaging MS-based molecular histology using graphical processing units.

Authors:  Emrys A Jones; René J M van Zeijl; Per E Andrén; André M Deelder; Lex Wolters; Liam A McDonnell
Journal:  J Am Soc Mass Spectrom       Date:  2012-02-04       Impact factor: 3.109

3.  Imaging mass spectrometry data reduction: automated feature identification and extraction.

Authors:  Liam A McDonnell; Alexandra van Remoortere; Nico de Velde; René J M van Zeijl; André M Deelder
Journal:  J Am Soc Mass Spectrom       Date:  2010-08-21       Impact factor: 3.109

Review 4.  Molecular imaging by mass spectrometry--looking beyond classical histology.

Authors:  Kristina Schwamborn; Richard M Caprioli
Journal:  Nat Rev Cancer       Date:  2010-08-19       Impact factor: 60.716

Review 5.  Mass spectrometric imaging for biomedical tissue analysis.

Authors:  Kamila Chughtai; Ron M A Heeren
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

6.  Imaging of phospholipids in formalin fixed rat brain sections by matrix assisted laser desorption/ionization mass spectrometry.

Authors:  Claire L Carter; Cameron W McLeod; Josephine Bunch
Journal:  J Am Soc Mass Spectrom       Date:  2011-09-01       Impact factor: 3.109

7.  Depicting the spatial distribution of proteins in human tumor tissue combining SELDI and MALDI imaging and immunohistochemistry.

Authors:  Liane Wehder; Günther Ernst; Anna C Crecelius; Orlando Guntinas-Lichius; Christian Melle; Ulrich S Schubert; Ferdinand von Eggeling
Journal:  J Histochem Cytochem       Date:  2010-07-19       Impact factor: 2.479

8.  Identification of Biomarkers of Necrosis in Xenografts Using Imaging Mass Spectrometry.

Authors:  Roberto Fernández; Jone Garate; Sergio Lage; Silvia Terés; Mónica Higuera; Joan Bestard-Escalas; Daniel H López; Francisca Guardiola-Serrano; Pablo V Escribá; Gwendolyn Barceló-Coblijn; José A Fernández
Journal:  J Am Soc Mass Spectrom       Date:  2015-09-25       Impact factor: 3.109

Review 9.  MALDI imaging mass spectrometry: state of the art technology in clinical proteomics.

Authors:  Julien Franck; Karim Arafah; Mohamed Elayed; David Bonnel; Daniele Vergara; Amélie Jacquet; Denis Vinatier; Maxence Wisztorski; Robert Day; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2009-05-18       Impact factor: 5.911

10.  MALDI Imaging Mass Spectrometry-A Mini Review of Methods and Recent Developments.

Authors:  Cecilia Eriksson; Noritaka Masaki; Ikuko Yao; Takahiro Hayasaka; Mitsutoshi Setou
Journal:  Mass Spectrom (Tokyo)       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.